Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost-Effectiveness Analysis-Reference-Cited by-同舟云学术

Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost-Effectiveness Analysis

Published:2018-12 Issue:6 Volume:200 Page:1215-1220
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Sathianathen Niranjan J.¹²,Kuntz Karen M.³,Alarid-Escudero Fernando³,Lawrentschuk Nathan L.²⁴,Bolton Damien M.²,Murphy Declan G.⁴,Weight Christopher J.¹,Konety Badrinath R.¹

Affiliation:

1. Department of Urology, University of Minnesota, Minneapolis, Minnesota

2. Department of Surgery, Urology Unit and Olivia Newton-John Cancer Research Institute Austin Health, University of Melbourne, Melbourne, Victoria, Australia

3. Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, Minnesota

4. Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference16 articles.

1. Prostate specific antigen for early detection of prostate cancer: longitudinal study;Holmström;BMJ,2009

2. Economic burden of cancer in the US: estimates, projections, and future research;Yabroff;Cancer Epidemiol Biomarkers Preven,2011

3. A multicenter study of [–2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range;Catalona;J Urol,2011

4. Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score;Van Neste;Eur Urol,2016

5. A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy;McKiernan;JAMA Oncol,2016

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer;Annals of Internal Medicine;2024-07

2. The Cost-Effectiveness of Prostate Cancer Screening That Incorporates Magnetic Resonance Imaging;Annals of Internal Medicine;2024-07

3. Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer;Prostate Cancer and Prostatic Diseases;2024-06-10

4. Urinary PSA-ZINC biomarker outperforms standard of care in early detection of prostate cancer;Minerva Urology and Nephrology;2024-06

5. Established and emerging liquid biomarkers for prostate cancer detection: A review;Urologic Oncology: Seminars and Original Investigations;2024-06